Clinical trial Recruiting at 7 sites Phase 2 Interventional Ages 18 and up

Using Argon for Ventilation After Cardiac Arrest

Official title: CardioPulmonary Resuscitation With Argon (CPAr) Trial

Run by Mario Negri Institute for Pharmacological Research · NCT05482945 · Data updated 2026-11-12

This study is testing if using argon gas mixed with oxygen can help protect the brain and heart in people who have just been resuscitated after a cardiac arrest.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorMario Negri Institute for Pharmacological Research
Academic / other
Locations9 sites (Genova, GE and 8 other locations)
StatusRecruiting
StartedMay 30, 2022
Main results expectedMarch 31, 2026
Study endsJune 30, 2026
Registry record updatedSeptember 17, 2025
Trial IDNCT05482945 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who have experienced a witnessed non-traumatic out-of-hospital cardiac arrest with a shockable rhythm.

Probably not a fit

Patients who suffered a non-witnessed cardiac arrest or have a non-shockable rhythm will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial investigates the use of argon gas as a ventilation mixture for patients who have been resuscitated from out-of-hospital cardiac arrest. It is a multicenter, randomized, controlled, single-blinded study focusing on safety assessments in a critical patient population. Eligible patients will receive argon in combination with oxygen within four hours of regaining spontaneous circulation, and outcomes will be monitored for six months. The study aims to determine if argon can reduce neurological and myocardial damage following cardiac arrest.

Why it matters

Potential benefit: If successful, this approach could significantly improve recovery outcomes for patients resuscitated from cardiac arrest.

How similar studies have gone: Previous studies have shown promising results with argon in animal models, but this is one of the first clinical trials to test its efficacy in humans.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ICU admission after resuscitation from witnessed non-traumatic out-of-hospital cardiac arrest (OHCA) of presumably cardiac etiology with a presenting shockable rhythm;
* age ≥ 18 years;
* unconsciousness after return of spontaneous circulation (ROSC);
* duration of CPR ≤ 40 mins;
* initiation of study intervention ≤ 4 hrs from ROSC;
* stable SaO2 ≥ 94% with a FiO2 of 30%.

Exclusion Criteria:

* Non-witnessed CA;
* CA of traumatic origin or from a non-presumably cardiac cause;
* CA with a non-shockable presenting rhythm (pulseless electrical activity and asystole);
* female of childbearing potential defined as younger of 50 years;
* pregnancy;
* known terminal illness;
* pre-CA cerebral performance category (CPC) ≥ 3;
* initiation of the study intervention \> 4 hrs from ROSC;
* participation to another clinical trial

Where it's running

  • Ospedale Policlinico San Martino di Genova
    Genova, Ge, Italy
    Recruiting
  • Ospedale San Gerado
    Monza, Mb, Italy
    Recruiting
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
    Milan, Milan, Italy
    Recruiting
  • Ospedale Civile Santa Maria degli Angeli di Pordenone
    Pordenone, Pordenone, Italy
    Recruiting
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS
    Roma, Rm, Italy
    Recruiting
  • Ospedale Santa Chiara di Trento
    Trento, Trento, Italy
    Recruiting
Show 3 more locations
  • Azienda Sanitaria Universitaria Giuliano Isontina (Asugi) di Trieste
    Trieste, Ts, Italy
    Recruiting
  • Azienda Ospedaliero - Universitaria di Parma
    Parma, Parma, Italy
    Not yet recruiting
  • Arcispedale Santa Maria Nuova di Reggio Emilia
    Reggio Emilia, Reggio Emilia, Italy
    Not yet recruiting

Study contacts

  • Principal investigator: Giuseppe Ristagno, MD, PhD — Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
  • Study coordinator: Giulia Merigo, MSc
  • Email: giulia.merigo@unimi.it
  • Phone: +39 0250320463

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.